ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,304, issued on April 7, was assigned to STCube & Co. Inc. (Seoul, South Korea).

"Antibodies specific to glycosylated LAG3 and methods of use thereof" was invented by Stephen S. Yoo (Centerville, Va.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Antibodies that selectively bind to glycosylated LAG3 relative to unglycosylated LAG3 are provided. In some aspects, LAG3 polypeptides comprising glycosylated amino acid positions are also provided. Methods for making and using such antibodies and polypeptides (e.g., for the treatment of cancer) are also provided."

The patent was filed on Oct. 9, 2020, under Application No. 17/767,894.

*For further informa...